Xencor, Inc. Common Stock (XNCR) News
Track canonical SquawkNews coverage tagged to XNCR, Xencor, Inc. Common Stock. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
XNCR - Xencor Reports Second Quarter 2026 Financial Results
XNCR - Xencor Reports Second Quarter 2026 Financial Results
EARNINGS | Aug 05, 2026, 08:04 PM UTC
H
WBLR Updates Analyst Conviction List
Adds and removes stocks from conviction list
EQUITY | Aug 03, 2026, 11:59 AM UTC
H
Xencor to receive $105M from Alexion
Xencor gets $105M from Alexion
EQUITY | Jul 29, 2026, 08:02 PM UTC
L
XNCR Xencor announces proffered Paper oral presentation at esmo 2026 for phase 1 clinical study of xmab819 in advanced clear cell renal cell
XNCR Xencor announces proffered Paper oral presentation at esmo 2026 for phase 1 clinical study of xmab819 in advanced clear cell renal cell carcinoma
EQUITY | Jul 17, 2026, 01:11 PM UTC
H
Xencor price target lowered to $27 from $29 at Truist
Truist lowered the firm's price target on Xencor to $27 from $29 and keeps a Buy rating on the shares as part of a broader research note updating the firm's models and previewing Q2 earnings in Biotech. The firm is antic
EARNINGS | Jul 07, 2026, 01:15 PM UTC